298 related articles for article (PubMed ID: 24754401)
1. Genotype/phenotype in tuberous sclerosis complex: associations with clinical and radiologic manifestations.
Kothare SV; Singh K; Hochman T; Chalifoux JR; Staley BA; Weiner HL; Menzer K; Devinsky O
Epilepsia; 2014 Jul; 55(7):1020-4. PubMed ID: 24754401
[TBL] [Abstract][Full Text] [Related]
2. Severity of manifestations in tuberous sclerosis complex in relation to genotype.
Kothare SV; Singh K; Chalifoux JR; Staley BA; Weiner HL; Menzer K; Devinsky O
Epilepsia; 2014 Jul; 55(7):1025-9. PubMed ID: 24917535
[TBL] [Abstract][Full Text] [Related]
3. Epilepsy and Neurodevelopmental Comorbidities in Tuberous Sclerosis Complex: A Natural History Study.
Gupta A; de Bruyn G; Tousseyn S; Krishnan B; Lagae L; Agarwal N;
Pediatr Neurol; 2020 May; 106():10-16. PubMed ID: 32139167
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for the development of autism spectrum disorder in children with tuberous sclerosis complex: protocol for a systematic review.
Mitchell R; Barton S; Harvey AS; Williams K
Syst Rev; 2017 Mar; 6(1):49. PubMed ID: 28270230
[TBL] [Abstract][Full Text] [Related]
5. TSC-associated neuropsychiatric disorders (TAND): findings from the TOSCA natural history study.
de Vries PJ; Belousova E; Benedik MP; Carter T; Cottin V; Curatolo P; Dahlin M; D'Amato L; d'Augères GB; Ferreira JC; Feucht M; Fladrowski C; Hertzberg C; Jozwiak S; Kingswood JC; Lawson JA; Macaya A; Marques R; Nabbout R; O'Callaghan F; Qin J; Sander V; Sauter M; Shah S; Takahashi Y; Touraine R; Youroukos S; Zonnenberg B; Jansen AC;
Orphanet J Rare Dis; 2018 Sep; 13(1):157. PubMed ID: 30201051
[TBL] [Abstract][Full Text] [Related]
6. Tuberous sclerosis complex: genotype/phenotype correlation of retinal findings.
Aronow ME; Nakagawa JA; Gupta A; Traboulsi EI; Singh AD
Ophthalmology; 2012 Sep; 119(9):1917-23. PubMed ID: 22608477
[TBL] [Abstract][Full Text] [Related]
7. Autism spectrum disorder in tuberous sclerosis complex: searching for risk markers.
Vignoli A; La Briola F; Peron A; Turner K; Vannicola C; Saccani M; Magnaghi E; Scornavacca GF; Canevini MP
Orphanet J Rare Dis; 2015 Dec; 10():154. PubMed ID: 26631248
[TBL] [Abstract][Full Text] [Related]
8. The coding and non-coding transcriptional landscape of subependymal giant cell astrocytomas.
Bongaarts A; van Scheppingen J; Korotkov A; Mijnsbergen C; Anink JJ; Jansen FE; Spliet WGM; den Dunnen WFA; Gruber VE; Scholl T; Samueli S; Hainfellner JA; Feucht M; Kotulska K; Jozwiak S; Grajkowska W; Buccoliero AM; Caporalini C; Giordano F; Genitori L; Coras R; Blümcke I; Krsek P; Zamecnik J; Meijer L; Scicluna BP; Schouten-van Meeteren AYN; Mühlebner A; Mills JD; Aronica E
Brain; 2020 Jan; 143(1):131-149. PubMed ID: 31834371
[TBL] [Abstract][Full Text] [Related]
9. TuberOus SClerosis registry to increase disease Awareness (TOSCA) - baseline data on 2093 patients.
Kingswood JC; d'Augères GB; Belousova E; Ferreira JC; Carter T; Castellana R; Cottin V; Curatolo P; Dahlin M; de Vries PJ; Feucht M; Fladrowski C; Gislimberti G; Hertzberg C; Jozwiak S; Lawson JA; Macaya A; Nabbout R; O'Callaghan F; Benedik MP; Qin J; Marques R; Sander V; Sauter M; Takahashi Y; Touraine R; Youroukos S; Zonnenberg B; Jansen AC;
Orphanet J Rare Dis; 2017 Jan; 12(1):2. PubMed ID: 28057044
[TBL] [Abstract][Full Text] [Related]
10. Recommendations for the radiological diagnosis and follow-up of neuropathological abnormalities associated with tuberous sclerosis complex.
Rovira À; Ruiz-Falcó ML; García-Esparza E; López-Laso E; Macaya A; Málaga I; Vázquez É; Vicente J
J Neurooncol; 2014 Jun; 118(2):205-223. PubMed ID: 24771286
[TBL] [Abstract][Full Text] [Related]
11. Systemic disease manifestations associated with epilepsy in tuberous sclerosis complex.
Jeong A; Wong M
Epilepsia; 2016 Sep; 57(9):1443-9. PubMed ID: 27417921
[TBL] [Abstract][Full Text] [Related]
12. Dose-level response rates of mTor inhibition in tuberous sclerosis complex (TSC) related subependymal giant cell astrocytoma (SEGA).
Weidman DR; Pole JD; Bouffet E; Taylor MD; Bartels U
Pediatr Blood Cancer; 2015 Oct; 62(10):1754-60. PubMed ID: 25929843
[TBL] [Abstract][Full Text] [Related]
13. Magnetic resonance imaging diagnosis of subependymal giant cell astrocytomas in follow-up of children with tuberous sclerosis complex: should we always use contrast enhancement?
Gaillard AL; Crombé A; Jecko V; Bessou P; Havez M; Pédespan JM; Van Gils J; Chateil JF
Pediatr Radiol; 2020 Sep; 50(10):1397-1408. PubMed ID: 32671416
[TBL] [Abstract][Full Text] [Related]
14. The TAND checklist: a useful screening tool in children with tuberous sclerosis and neurofibromatosis type 1.
Cervi F; Saletti V; Turner K; Peron A; Bulgheroni S; Taddei M; La Briola F; Canevini MP; Vignoli A
Orphanet J Rare Dis; 2020 Sep; 15(1):237. PubMed ID: 32894194
[TBL] [Abstract][Full Text] [Related]
15. Surgical resection of subependymal giant cell astrocytomas (SEGAs) and changes in SEGA-related conditions: a US national claims database study.
Sun P; Krueger D; Liu J; Guo A; Rogerio J; Kohrman M
Curr Med Res Opin; 2012 Apr; 28(4):651-6. PubMed ID: 22375957
[TBL] [Abstract][Full Text] [Related]
16. Isolated subependymal giant cell astrocytoma (SEGA) in the absence of clinical tuberous sclerosis: two case reports and literature review.
Cobourn KD; Chesney KM; Mueller K; Fayed I; Tsering D; Keating RF
Childs Nerv Syst; 2024 Jan; 40(1):73-78. PubMed ID: 37658938
[TBL] [Abstract][Full Text] [Related]
17. The autism spectrum disorder phenotype in children with tuberous sclerosis complex: A systematic review and meta-analysis.
Mitchell RA; Mitchell M; Williams K
Dev Med Child Neurol; 2022 Oct; 64(10):1214-1229. PubMed ID: 35724267
[TBL] [Abstract][Full Text] [Related]
18. The relationship of neuroimaging findings and neuropsychiatric comorbidities in children with tuberous sclerosis complex.
Huang CH; Peng SS; Weng WC; Su YN; Lee WT;
J Formos Med Assoc; 2015 Sep; 114(9):849-54. PubMed ID: 24698169
[TBL] [Abstract][Full Text] [Related]
19. TSC2 somatic mosaic mutation, including extra-tumor tissue, may be the developmental cause of solitary subependymal giant cell astrocytoma.
Sasaki T; Uda T; Kuki I; Kunihiro N; Okazaki S; Niida Y; Goto T
Childs Nerv Syst; 2022 Jan; 38(1):77-83. PubMed ID: 34741623
[TBL] [Abstract][Full Text] [Related]
20. Long-term effect of everolimus on epilepsy and growth in children under 3 years of age treated for subependymal giant cell astrocytoma associated with tuberous sclerosis complex.
Kotulska K; Chmielewski D; Borkowska J; Jurkiewicz E; Kuczyński D; Kmieć T; Łojszczyk B; Dunin-Wąsowicz D; Jóźwiak S
Eur J Paediatr Neurol; 2013 Sep; 17(5):479-85. PubMed ID: 23567018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
